140 related articles for article (PubMed ID: 12496475)
21. Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11.
Landrette SF; Kuo YH; Hensen K; Barjesteh van Waalwijk van Doorn-Khosrovani S; Perrat PN; Van de Ven WJ; Delwel R; Castilla LH
Blood; 2005 Apr; 105(7):2900-7. PubMed ID: 15585652
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of core-binding factor alpha (CBF alpha) reverses cellular transformation by the CBF beta-smooth muscle myosin heavy chain chimeric oncoprotein.
Hajra A; Liu PP; Speck NA; Collins FS
Mol Cell Biol; 1995 Sep; 15(9):4980-9. PubMed ID: 7651416
[TBL] [Abstract][Full Text] [Related]
23. HDAC1 Is a Required Cofactor of CBFβ-SMMHC and a Potential Therapeutic Target in Inversion 16 Acute Myeloid Leukemia.
Richter LE; Wang Y; Becker ME; Coburn RA; Williams JT; Amador C; Hyde RK
Mol Cancer Res; 2019 Jun; 17(6):1241-1252. PubMed ID: 30814129
[TBL] [Abstract][Full Text] [Related]
24. CBFβ-SMMHC Affects Genome-wide Polycomb Repressive Complex 1 Activity in Acute Myeloid Leukemia.
Cordonnier G; Mandoli A; Cagnard N; Hypolite G; Lhermitte L; Verhoeyen E; Asnafi V; Dillon N; Macintyre E; Martens JHA; Bond J
Cell Rep; 2020 Jan; 30(2):299-307.e3. PubMed ID: 31940477
[TBL] [Abstract][Full Text] [Related]
25. The chimeric protein, PEBP2 beta/CBF beta-SMMHC, disorganizes cytoplasmic stress fibers and inhibits transcriptional activation.
Tanaka Y; Fujii M; Hayashi K; Chiba N; Akaishi T; Shineha R; Nishihira T; Satomi S; Ito Y; Watanabe T; Satake M
Oncogene; 1998 Aug; 17(6):699-708. PubMed ID: 9715271
[TBL] [Abstract][Full Text] [Related]
26. Leukemogenesis by CBF oncoproteins.
Friedman AD
Leukemia; 1999 Dec; 13(12):1932-42. PubMed ID: 10602413
[TBL] [Abstract][Full Text] [Related]
27. Cbfbeta-SMMHC impairs differentiation of common lymphoid progenitors and reveals an essential role for RUNX in early B-cell development.
Kuo YH; Gerstein RM; Castilla LH
Blood; 2008 Feb; 111(3):1543-51. PubMed ID: 17940206
[TBL] [Abstract][Full Text] [Related]
28. Targeting binding partners of the CBFβ-SMMHC fusion protein for the treatment of inversion 16 acute myeloid leukemia.
Richter L; Wang Y; Hyde RK
Oncotarget; 2016 Oct; 7(40):66255-66266. PubMed ID: 27542261
[TBL] [Abstract][Full Text] [Related]
29. NrasG12D oncoprotein inhibits apoptosis of preleukemic cells expressing Cbfβ-SMMHC via activation of MEK/ERK axis.
Xue L; Pulikkan JA; Valk PJ; Castilla LH
Blood; 2014 Jul; 124(3):426-36. PubMed ID: 24894773
[TBL] [Abstract][Full Text] [Related]
30. Runx2 induces acute myeloid leukemia in cooperation with Cbfbeta-SMMHC in mice.
Kuo YH; Zaidi SK; Gornostaeva S; Komori T; Stein GS; Castilla LH
Blood; 2009 Apr; 113(14):3323-32. PubMed ID: 19179305
[TBL] [Abstract][Full Text] [Related]
31. Chemical biology. A small-molecule inhibitor of the aberrant transcription factor CBFβ-SMMHC delays leukemia in mice.
Illendula A; Pulikkan JA; Zong H; Grembecka J; Xue L; Sen S; Zhou Y; Boulton A; Kuntimaddi A; Gao Y; Rajewski RA; Guzman ML; Castilla LH; Bushweller JH
Science; 2015 Feb; 347(6223):779-84. PubMed ID: 25678665
[TBL] [Abstract][Full Text] [Related]
32. Methylation-independent silencing of the tumor suppressor INK4b (p15) by CBFbeta-SMMHC in acute myelogenous leukemia with inv(16).
Markus J; Garin MT; Bies J; Galili N; Raza A; Thirman MJ; Le Beau MM; Rowley JD; Liu PP; Wolff L
Cancer Res; 2007 Feb; 67(3):992-1000. PubMed ID: 17283131
[TBL] [Abstract][Full Text] [Related]
33. Identification of a region on the outer surface of the CBFbeta-SMMHC myeloid oncoprotein assembly competence domain critical for multimerization.
Zhang L; D'Costa J; Kummalue T; Civin CI; Friedman AD
Oncogene; 2006 Nov; 25(55):7289-96. PubMed ID: 16767164
[TBL] [Abstract][Full Text] [Related]
34. RUNX1 and CBFβ-SMMHC transactivate target genes together in abnormal myeloid progenitors for leukemia development.
Zhen T; Cao Y; Ren G; Zhao L; Hyde RK; Lopez G; Feng D; Alemu L; Zhao K; Liu PP
Blood; 2020 Nov; 136(21):2373-2385. PubMed ID: 32929473
[TBL] [Abstract][Full Text] [Related]
35. Molecular basis for a dominant inactivation of RUNX1/AML1 by the leukemogenic inversion 16 chimera.
Huang G; Shigesada K; Wee HJ; Liu PP; Osato M; Ito Y
Blood; 2004 Apr; 103(8):3200-7. PubMed ID: 15070703
[TBL] [Abstract][Full Text] [Related]
36. The leukemic core binding factor beta-smooth muscle myosin heavy chain (CBF beta-SMMHC) chimeric protein requires both CBF beta and myosin heavy chain domains for transformation of NIH 3T3 cells.
Hajra A; Liu PP; Wang Q; Kelley CA; Stacy T; Adelstein RS; Speck NA; Collins FS
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):1926-30. PubMed ID: 7892201
[TBL] [Abstract][Full Text] [Related]
37. Monitoring AML1-ETO and CBFbeta-MYH11 transcripts in acute myeloid leukemia.
Yin JA; Frost L
Curr Oncol Rep; 2003 Sep; 5(5):399-404. PubMed ID: 12895392
[TBL] [Abstract][Full Text] [Related]
38. Unlike AML1, CBFbeta gene is not deregulated by point mutations in acute myeloid leukemia and in myelodysplastic syndromes.
Leroy H; Roumier C; Grardel-Duflos N; Macintyre E; Lepelley P; Fenaux P; Preudhomme C
Blood; 2002 May; 99(10):3848-50. PubMed ID: 11986246
[TBL] [Abstract][Full Text] [Related]
39. The PEBP2beta/CBF beta-SMMHC chimeric protein is localized both in the cell membrane and nuclear subfractions of leukemic cells carrying chromosomal inversion 16.
Kanto S; Chiba N; Tanaka Y; Fujita S; Endo M; Kamada N; Yoshikawa K; Fukuzaki A; Orikasa S; Watanabe T; Satake M
Leukemia; 2000 Jul; 14(7):1253-9. PubMed ID: 10914550
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of leukemogenesis by the inv(16) chimeric gene CBFB/PEBP2B-MHY11.
Shigesada K; van de Sluis B; Liu PP
Oncogene; 2004 May; 23(24):4297-307. PubMed ID: 15156186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]